MGROF (MustGrow Biologics) Long-Term Debt: $0.10 Mil (As of Mar. 2026)


MGROF MustGrow Biologics Corp MGROF
29 GF Score
Price $0.28
! 3 Warning Signs
View Full Analysis

What is MustGrow Biologics Long-Term Debt?

MustGrow Biologics MGROF +0.88% 29 Long-Term Debt is $0.10 Mil as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

MustGrow Biologics's Long-Term Debt for the quarter that ended in Mar. 2026 was $0.10 Mil.

MustGrow Biologics's quarterly Long-Term Debt increased from Sep. 2025 ($0.09 Mil) to Dec. 2025 ($0.10 Mil) and increased from Dec. 2025 ($0.10 Mil) to Mar. 2026 ($0.10 Mil).

MustGrow Biologics's annual Long-Term Debt declined from Dec. 2023 ($0.11 Mil) to Dec. 2024 ($0.09 Mil) but then increased from Dec. 2024 ($0.09 Mil) to Dec. 2025 ($0.10 Mil).

MustGrow Biologics  (OTCPK:MGROF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

MustGrow Biologics Long-Term Debt Related Terms

MustGrow Biologics Long-Term Debt Historical Data

* Premium members only.

The historical data trend for MustGrow Biologics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MustGrow Biologics Long-Term Debt Chart

MustGrow Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.26 0.11 0.09 0.10

MustGrow Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 1.89 0.09 0.10 0.10
MGROF
29GF Score
MustGrow Biologics Corp MGROF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.10 Mil mean?
MustGrow Biologics (MGROF) has a Long-Term Debt of $0.10 Mil as of Mar. 2026.
Is MustGrow Biologics' Long-Term Debt too high?
MustGrow Biologics' current Long-Term Debt is $0.10 Mil. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Long-Term Debt compare to CTVA and CF?
MustGrow Biologics' Long-Term Debt of $0.10 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for an Agriculture company?
A good Long-Term Debt depends on the Agriculture industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. MustGrow Biologics's current Long-Term Debt is $0.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Long-Term Debt of $0.10 Mil. The current Long-Term Debt is $0.10 Mil. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Long-Term Debt is $0.10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MustGrow Biologics Business Description

Other Exchanges 0C0:GermanyMGRO:Canada
Address 1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score

Get the complete analysis for MGROF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price